{
    "clinical_study": {
        "@rank": "20067", 
        "arm_group": {
            "arm_group_label": "Avance foam, abdominal dressing kit", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The investigation is a Post Marketing Follow-Up Study for the Avance Foam Abdominal Dressing\n      Kit conducted as part of M\u00f6lnlycke Health Care's quality system. The primary objective is to\n      evaluate the dressing kit as part of a negative pressure system. The secondary objectives\n      are to collect and evaluate safety data, performance data and information on technical\n      complications."
        }, 
        "brief_title": "Post Market Clinical Follow Up Study of Avance Foam Abdominal Dressing Kit in Open Abdomen", 
        "condition": "Open Abdomen", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Provision of written informed consent from subject or family member\n\n          2. Subjects with open abdomen suitable for temporary closure with NPWT therapy\n\n          3. Subjects where the viscera and/or abdominal organs need to be protected by an\n             abdominal organ contact layer (OCL)\n\n          4. Subject which (at the time of the baseline visit) are planned to be cared for between\n             dressing changes at Intensive Care Unit\n\n          5. Male or female, 18 years and above\n\n        Exclusion Criteria:\n\n          1. Synthetic mesh inserted in the abdomen\n\n          2. Non-enteric fistulae or unexplored fistulas\n\n          3. Untreated osteomyelitis\n\n          4. Malignant wounds\n\n          5. Abdominal  wall hernia\n\n          6. Subjects previously treated with an NPWT abdominal dressing\n\n          7. Known allergy or hypersensitivity to any of the components in the dressing\n\n          8. Pregnancy\n\n          9. Subjects not suitable for the investigation according to the investigator's judgement\n\n         10. Subjects included in other ongoing clinical investigation at present which could\n             interfere with this investigation, as judged by the investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01968811", 
            "org_study_id": "Avance A01"
        }, 
        "intervention": {
            "arm_group_label": "Avance foam, abdominal dressing kit", 
            "intervention_name": "Avance Foam dressing kit", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "G\u00f6teborg", 
                    "country": "Sweden", 
                    "zip": "41345"
                }, 
                "name": "Sahlgrenska University hospital"
            }
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multi-Centre, Post CE Mark, Open Clinical Investigation to Evaluate an Abdominal NPWT (Negative Pressure Wound Therapy) System (Avance\u00ae Pump and Avance\u00ae Foam Abdominal Dressing Kit) in Subjects With Open Abdominal Wounds", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of participants with Adverse events as a Measure of Safety and tolerability.", 
            "safety_issue": "No", 
            "time_frame": "participants will be followed until abdominal closure or until insertion of synthetic mesh, an expected avarage of 10 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01968811"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "- Fascial/Skin closure of the open abdomen", 
            "safety_issue": "No", 
            "time_frame": "At end of treatment, an expected average is 10 days."
        }, 
        "source": "Molnlycke Health Care AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Molnlycke Health Care AB", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}